Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Pharma
Pfizer partner touts HER2 ADC trial win in bladder cancer
RemeGen's China readout bodes well for Pfizer’s own global phase 3 trial that pairs disitamab vedotin with Keytruda in first-line bladder cancer.
Angus Liu
May 12, 2025 10:59am
Enhertu, Takeda, Trump—Fierce Pharma Asia
May 9, 2025 6:15am
Akeso, AstraZeneca, Ono—Fierce Pharma Asia
May 2, 2025 7:58am
Akeso CEO tries to reset expectations of bispecific's OS readout
Apr 28, 2025 6:50am
Akeso’s Anniko enters crowded US PD-1 market
Apr 25, 2025 10:55am
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Apr 25, 2025 8:45am
